RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa
Massachusetts General Hospital, Boston MA
Investigators
Linked publications & trials
Abstract
The purpose of this study is to investigate the effects of nutritional and hormonal factors on bone turnover and bone density in women with anorexia nervosa. One aim of the study will be to determine the time course and quantitative effects of short-term, low dose, rhIGF-I administration one bone turnover in estrogen-treated vs. nonestrogen-treated women with anorexia nervosa. The second aim is to investigate the long term effects of combined estrogen and rhIGF-I one bone density in anorexia nervosa; for this part of the study, anorectic subjects with established bone loss will be randomized to recieve one or both treatments for a period of nine months. Continuing review of the project referenced above reveals that 73 human subjects (73 females, 2 minorities) have been enrolled to date. The investigators report that one subject was withdrawn due to an allergic reaction. Enrollment in the study continues to be active. Data analysis will not take place until end of study.
View original record on NIH RePORTER →